CASU, Gavino
 Distribuzione geografica
Continente #
SA - Sud America 1.469
AS - Asia 1.361
EU - Europa 734
NA - Nord America 609
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 4.252
Nazione #
BR - Brasile 1.322
SG - Singapore 784
US - Stati Uniti d'America 551
IT - Italia 305
CN - Cina 173
HK - Hong Kong 154
DE - Germania 112
UA - Ucraina 73
FI - Finlandia 51
RU - Federazione Russa 50
TR - Turchia 44
AR - Argentina 41
EC - Ecuador 31
UZ - Uzbekistan 31
IQ - Iraq 29
VE - Venezuela 24
KR - Corea 23
AT - Austria 21
MX - Messico 21
SE - Svezia 20
BD - Bangladesh 18
ZA - Sudafrica 18
CO - Colombia 17
CZ - Repubblica Ceca 17
NL - Olanda 16
CA - Canada 15
FR - Francia 15
MA - Marocco 15
GB - Regno Unito 13
IN - India 12
PK - Pakistan 12
AZ - Azerbaigian 11
TN - Tunisia 11
DZ - Algeria 10
KE - Kenya 9
KZ - Kazakistan 9
PE - Perù 9
UY - Uruguay 9
NP - Nepal 8
BE - Belgio 7
JO - Giordania 7
KG - Kirghizistan 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
LB - Libano 6
PA - Panama 6
ID - Indonesia 5
LT - Lituania 5
AL - Albania 4
AU - Australia 4
DO - Repubblica Dominicana 4
RO - Romania 4
RS - Serbia 4
XK - ???statistics.table.value.countryCode.XK??? 4
CR - Costa Rica 3
HN - Honduras 3
SA - Arabia Saudita 3
SN - Senegal 3
BN - Brunei Darussalam 2
BO - Bolivia 2
ES - Italia 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
JP - Giappone 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
TW - Taiwan 2
AO - Angola 1
BG - Bulgaria 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EG - Egitto 1
GY - Guiana 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
NG - Nigeria 1
PL - Polonia 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 4.252
Città #
Singapore 436
Hong Kong 154
Shanghai 112
São Paulo 91
Chandler 67
Dallas 66
Belo Horizonte 48
Santa Clara 40
Helsinki 36
Jacksonville 33
Rio de Janeiro 33
Munich 32
Tashkent 28
Nuremberg 27
Curitiba 26
Romola 26
Brasília 25
Seoul 23
Princeton 22
Ann Arbor 20
Boardman 20
Sassari 19
Wilmington 19
Campinas 17
Rome 16
Falkenstein 15
Guarulhos 15
Ribeirão Preto 15
Vienna 14
Baghdad 13
Cagliari 13
Dearborn 13
Nanjing 13
Porto Alegre 13
Salvador 13
Brno 12
Istanbul 12
Baku 11
Milan 11
Quito 11
Ashburn 10
New York 10
Uberlândia 10
Guayaquil 9
Nuoro 9
Santo André 9
São José dos Campos 9
Belford Roxo 8
Betim 8
Florianópolis 8
Lima 8
Los Angeles 8
Mauá 8
Montevideo 8
Nairobi 8
Sorocaba 8
Woodbridge 8
Aracaju 7
Bogotá 7
Brussels 7
Caracas 7
Frankfurt am Main 7
Ipatinga 7
Joinville 7
Jundiaí 7
Manaus 7
Toronto 7
Amman 6
Bishkek 6
Campos dos Goytacazes 6
Fortaleza 6
Goiânia 6
Gravataí 6
Lappeenranta 6
Maceió 6
Mogi das Cruzes 6
Ottawa 6
Pelotas 6
São José do Rio Preto 6
Águas Lindas de Goiás 6
Beijing 5
Belém 5
Campo Grande 5
Canoas 5
Cape Town 5
Caratinga 5
Cuiabá 5
Dhaka 5
Florence 5
Franca 5
Jaboatão dos Guararapes 5
Jacareí 5
Johannesburg 5
João Pessoa 5
Juiz de Fora 5
London 5
Marília 5
Medellín 5
Natal 5
Nova Iguaçu 5
Totale 2.024
Nome #
Brain anticipatory cardiovascular responses to exercise 110
Follicular spicules and multiple ulcers: cutaneous manifestations of multiple myeloma 85
Serum albumin and mortality risk in old patients with acute ischemic stroke. 74
Albumina plasmatica come indice prognostico nei pazienti con ictus cerebrale ischemico. 68
Spicule follicolari del volto: una manifestazione cutanea peculiare del mieloma multiplo con crioglobulinemia 66
Effect of rhTSH on Lipids 58
Ictus cerebale ischemico e infiammazione: nuovi indici di prognosi. 57
Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta-Analysis of Randomized Trials 52
Cerebral amyloid angiopathy and atrial fibrillation: a dangerous combination 52
Highly specialized stroke care improves the 30-day survival 51
Aging of the Arterial System 50
Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation 49
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study 47
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry 44
Vascular assisted-tracking for challenging transradial percutaneous intervention 43
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension 40
Left Atrial Appendage Occlusion in Patients With Non-Valvular Atrial Fibrillation and Cerebral Amyloid Angiopathy: Insights From the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 39
EFNB2 haploinsufficiency causes a syndromic neurodevelopmental disorder 39
Clinical outcomes of left atrial appendage occlusion in patients with previous intracranial or gastrointestinal bleeding: Insights from the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 38
Efficacy and Safety of P2Y12 monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trials 37
Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists 37
Abstract 110: Quality of life in Beta Thalassemia 37
The Italian registry of renal denervation 36
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: Indications, patient selection, staff skills, organisation, and training 36
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 36
Association of chromosome 9p21 with subsequent coronary heart disease events: A GENIUS-CHD study of individual participant data 36
Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study 36
Safety, efficacy, and reproducibility of cavotricuspid isthmus ablation guided by the ablation index: Acute results of the FLAI study 35
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2021), 34, 1, (63-73), 10.1007/s40620-020-00774-5) 35
Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study 34
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study 34
Antegrade fenestration and re-entry for bailout treatment of iatrogenic coronary dissection 34
Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: Insights fromthe EYESHOT study 34
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 33
Clinical application of virtual reality in patients with cardiovascular disease: state of the art 33
Atrial Fibrillation in Patients Undergoing Transcatheter Mitral Valve Repair: More Than Meets the Eye? 33
"A heterozygous mutation of the elastin gene ( ELN: p.val154met) fully co-segregates with classic marfan phenotype in a sardinian family: a possible novel disease-gene?" 32
Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study 32
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 32
Integrating Pharmacological Features to Personalized Models With Statin Therapy 32
The balloon-assisted tracking technique for challenging femoral vascular access 31
A double left anterior descending coronary artery emerging from the right Valsalva sinus: A case report and a brief literature review 31
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus 31
Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links 31
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2) 31
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 31
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature 31
Spontaneous Retrograde Embolization From an Infarct-Related Artery to a Bystander Nonculprit Artery: An Unclear Pathophysiological Mechanism? 30
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: Indications, patient selection, competences, organization, and operator training 30
Long‐term gender disparities in new‐onset heart failure after acute coronary syndrome 30
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 30
Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry 30
When Atrial Fibrillation Meets Cerebral Amyloid Angiopathy: Current Evidence and Strategies 29
Intra-Cardiac versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion with a Watchman FLX Device 29
Integration of “Omics” Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome 29
La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: dati al basale del Registro Europeo PREFER in AF 28
Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: The ATA AF study 28
Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator 28
Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension 28
Humankind versus Virus: Are we winning the battle but losing the war? 28
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 28
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 28
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint 28
Diuretic therapy in heart failure - Current approaches 27
Atrial fibrillation in severe and end stage renal disease: from oral anticoagulation therapy to percutaneous left atrial appendage occlusion 27
Dosing of clopidogrel and aspirin in acute coronary syndromes [2] 27
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry 27
Clinical Impact of Revascularization Extent in Patients Undergoing Impella-Protected PCI Enrolled in a Nationwide Registry 27
Letter to the editor 27
Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island 27
Improving adherence to rehabilitation for heart failure patients through immersive virtual reality (VIRTUAL-HF): A protocol for a randomized controlled trial 27
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 27
Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study 27
Anomalous origin of right coronary artery from left sinus of valsalva 26
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosis 26
Allergic Myocardial Infarction: An Unusual Cause of Stent Thrombosis 26
Theoretical basis for a new approach of studying Emery-Dreifuss muscular dystrophy by means of thermography 26
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 26
Effectiveness of virtual reality on pain and anxiety in patients undergoing cardiac procedures: A systematic review and meta-analysis of randomized controlled trials 26
Percutaneous Management of Left Atrial Appendage Perforation: Keep Calm and Think Fast 26
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry 26
Diagnosis of Brugada syndrome affects quality of life and psychological status 26
An Impressive Case of "honeycomb" In-Stent Restenosis 25
Spontaneous Intracerebral Hemorrhage 25
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review 25
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension 25
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology 25
Correspondence 25
Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: A pre-specified analysis of the MATRIX trial 24
Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry) 24
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry 24
Relationship between infrared skin radiation and muscular strength tests in patients affected by Emery-Dreifuss muscular dystrophy 24
The strategic alliance between clinical and molecular science in the war against sars-cov-2, with the rapid-diagnostics test as an indispensable weapon for front line doctors 24
An ensemble machine learning approach for predicting heart failure risk in acute coronary syndrome patients: heartguardai 24
Rapid and portable, lab-on-chip, point-of-care genotyping for evaluating clopidogrel metabolism 24
Rendered OCT imaging of an impressive stent malapposition in the left main coronary artery 24
Impact of Selection Bias on Estimation of Subsequent Event Risk 24
Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion 24
Brugada phenocopy in a patient with unstable angina and three-vessel coronary artery disease 23
The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective 23
Totale 3.404
Categoria #
all - tutte 23.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.081


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 0 0 0 0 0 7 8 11 2
2020/2021136 11 0 59 4 10 6 11 0 12 15 6 2
2021/202247 9 0 2 1 0 1 1 2 5 1 5 20
2022/2023119 16 12 7 20 7 18 0 12 19 2 5 1
2023/2024493 12 2 1 2 11 4 5 187 0 17 80 172
2024/20253.514 16 91 292 132 172 200 258 856 1.497 0 0 0
Totale 4.446